Detalhe da pesquisa
1.
Macrod1 suppresses diabetic cardiomyopathy via regulating PARP1-NAD+-SIRT3 pathway.
Acta Pharmacol Sin
; 45(6): 1175-1188, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459256
2.
Mangiferin alleviates diabetic pulmonary fibrosis in mice via inhibiting endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis.
Acta Pharmacol Sin
; 45(5): 1002-1018, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225395
3.
Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways.
Acta Pharmacol Sin
; 43(8): 1989-2002, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34916609
4.
Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathway.
Biomed Pharmacother
; 174: 116589, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636400
5.
ADP-ribosylation: An emerging direction for disease treatment.
Ageing Res Rev
; 94: 102176, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141734
6.
Identify Tcea3 as a novel anti-cardiomyocyte hypertrophy gene involved in fatty acid oxidation and oxidative stress.
Front Cardiovasc Med
; 10: 1137429, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404738
7.
Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy.
Front Cardiovasc Med
; 9: 853468, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35433888
8.
Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy.
Br J Pharmacol
; 179(18): 4516-4533, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727596
9.
Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway.
Oxid Med Cell Longev
; 2022: 8367997, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35242278